Incyte and AstraZeneca to enter Clinical Trial Collaboration in Early Lung Cancer
Incyte Corporation and MedImmune, AstraZeneca’s global biologics research and development arm, announced the expansion of their clinical collaboration. As part of the agreement, the…
Read More...
Read More...
